Genetic Toxicology Testing
New Gene Tox Assay: BioReliance has introduced a new assay, the Reconstructed Skin Micronucleus Assay (RSMN), to detect possible DNA damage from products with dermal routes of exposure. Please click here for further information.
BioReliance offers genetic toxicology services for the detection of toxic, mutagenic, clastogenic, and morphological transforming activity in a number of well-characterized test systems. Our scientific staff and state-of-the-art facilities provide the most current and comprehensive genetic toxicology resources available anywhere.
BioReliance offers individual toxicology assays or can tailor a comprehensive testing program for your specific needs. Protocols are designed according to international guidelines (FDA, EPA, OECD, EU, JMHW, and JMAFF) and are conducted in full compliance with Good Laboratory Practice (GLP) standards. We apply the most current battery of tests available for the detection of genotoxic potential.
Our genetic toxicology services (Gene Tox) can identify genotoxic agents to humans. Gene Tox assays support interpretation of other toxicology results, provide support for regulatory decisions, alert producers and users of potential hazard and help with drug discovery decisions.
Click here for additional assay and services information for Genetic Toxicology.